The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases, Clin Orthop Relat Res, vol.262, pp.3-11, 1893. ,
From mice to humans: developments in cancer immunoediting, Journal of Clinical Investigation, vol.125, issue.9, pp.3338-3346, 2015. ,
DOI : 10.1172/JCI80004
Immune infiltration in human tumors: a prognostic factor that should not be ignored, Oncogene, vol.173, issue.8, pp.1093-1102, 2010. ,
DOI : 10.1038/nrc1586
T cells in anti-tumor immune responses, Immunological Reviews, vol.161, issue.1, pp.129-144, 2008. ,
DOI : 10.1038/nbt1215
Orchestration of Angiogenesis by Immune Cells, Frontiers in Oncology, vol.121, issue.3, p.131, 2014. ,
DOI : 10.1016/j.cell.2005.02.034
Tumorinduced perturbations of cytokines and immune cell networks, Biochim Biophys Acta, vol.1845, issue.2, pp.182-201, 2014. ,
Endogenous Interleukin-4 Promotes Tumor Development by Increasing Tumor Cell Resistance to Apoptosis, Cancer Research, vol.68, issue.21, pp.8687-8694, 2008. ,
DOI : 10.1158/0008-5472.CAN-08-0449
Role of IL-13 in regulation of anti-tumor immunity and tumor growth, Cancer Immunology, Immunotherapy, vol.53, issue.2, pp.79-85, 2004. ,
DOI : 10.1007/s00262-003-0445-0
Natural and Induced T Regulatory Cells in Cancer, Frontiers in Immunology, vol.4, p.190, 2013. ,
DOI : 10.3389/fimmu.2013.00190
Induced and natural regulatory T cells in human cancer, Expert Opinion on Biological Therapy, vol.155, issue.10, pp.1383-1397, 2012. ,
DOI : 10.1007/s00262-011-1171-7
Th17 Cells in Cancer: The Ultimate Identity Crisis, Frontiers in Immunology, vol.115, issue.6, p.276, 2014. ,
DOI : 10.4161/self.2.2.15832
IL-17 can promote tumor growth through an IL-6???Stat3 signaling pathway, The Journal of Experimental Medicine, vol.206, issue.7, pp.1457-1464, 2009. ,
DOI : 10.1016/j.jhep.2008.12.033
Tumor-specific Th17-polarized cells eradicate large established melanoma, Blood, vol.112, issue.2, pp.362-373, 2008. ,
DOI : 10.1182/blood-2007-11-120998
T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity, Immunity, vol.31, issue.5, pp.787-798, 2009. ,
DOI : 10.1016/j.immuni.2009.09.014
URL : http://doi.org/10.1016/j.immuni.2009.09.014
Transforming growth factor-?? 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9???producing subset, Nature Immunology, vol.194, issue.12, pp.1341-1346, 2008. ,
DOI : 10.1038/ni.1659
IL-4 inhibits TGF-??-induced Foxp3+ T cells and, together with TGF-??, generates IL-9+ IL-10+ Foxp3??? effector T cells, Nature Immunology, vol.201, issue.12, pp.1347-1355, 2008. ,
DOI : 10.1038/ni.1677
Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity., Proceedings of the National Academy of Sciences, vol.85, issue.18, pp.6934-6938, 1988. ,
DOI : 10.1073/pnas.85.18.6934
Increased serum levels of interleukin-9 correlate to negative prognostic factors in Hodgkin's lymphoma, Leukemia, vol.17, issue.12, pp.2513-2516, 2003. ,
DOI : 10.1038/sj.leu.2403123
IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells, Proceedings of the National Academy of Sciences, vol.106, issue.31, pp.12885-12890, 2009. ,
DOI : 10.1073/pnas.0812530106
Inhibition of Adaptive Immunity by IL9 Can Be Disrupted to Achieve Rapid T-cell Sensitization and Rejection of Progressive Tumor Challenges, Cancer Research, vol.74, issue.23, pp.6845-6855, 2014. ,
DOI : 10.1158/0008-5472.CAN-14-0836
Robust tumor immunity to melanoma mediated by interleukin-9???producing T cells, Nature Medicine, vol.178, issue.8, pp.1248-1253, 2012. ,
DOI : 10.1097/SHK.0b013e31821af669
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518666
The DNA-binding inhibitor Id3 regulates IL-9 production in CD4+ T cells, Nature Immunology, vol.513, issue.10, pp.1077-1084, 2015. ,
DOI : 10.1038/ni.1997
IL-9 Production by Regulatory T Cells Recruits Mast Cells That Are Essential for Regulatory T Cell-Induced Immune Suppression, The Journal of Immunology, vol.186, issue.1, pp.83-91, 2011. ,
DOI : 10.4049/jimmunol.1001183
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227733
Mast Cell-Deficient W-sash c-kit Mutant KitW-sh/W-sh Mice as a Model for Investigating Mast Cell Biology in Vivo, The American Journal of Pathology, vol.167, issue.3, pp.835-848, 2005. ,
DOI : 10.1016/S0002-9440(10)62055-X
9 immunity accompanied by mast cell activation blocks tumor cell engraftment, International Journal of Cancer, vol.53, issue.4, pp.841-853, 2016. ,
DOI : 10.1002/ijc.30121
Th9 cells promote antitumor immune responses in vivo, Journal of Clinical Investigation, vol.122, issue.11, pp.4160-4171, 2012. ,
DOI : 10.1172/JCI65459DS1
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484462
Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells, Nature Communications, vol.110, p.12368, 2016. ,
DOI : 10.1038/ncomms12368
The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells, Nature Immunology, vol.153, issue.8, pp.758-766, 2014. ,
DOI : 10.1038/nbt.1621
Murine Th9 cells promote the survival of myeloid dendritic cells in cancer immunotherapy, Cancer Immunology, Immunotherapy, vol.311, issue.5764, pp.835-845, 2014. ,
DOI : 10.1007/s00262-014-1557-4
Glucocorticoid-induced tumor necrosis factor receptor???related protein co-stimulation facilitates tumor regression by inducing IL-9???producing helper T cells, Nature Medicine, vol.21, issue.9, pp.1010-1017, 2015. ,
DOI : 10.1111/j.1365-2567.2006.02453.x
GITR subverts Foxp3+ Tregs to boost Th9 immunity through regulation of histone acetylation, Nature Communications, vol.118, p.8266, 2015. ,
DOI : 10.1016/j.immuni.2010.07.014
IL-9 inhibits HTB-72 melanoma cell growth through upregulation of p21 and TRAIL, Journal of Surgical Oncology, vol.8, issue.8, pp.969-974, 2015. ,
DOI : 10.1002/jso.23930
An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation, Nature Immunology, vol.148, issue.11, pp.1071-1077, 2011. ,
DOI : 10.4049/jimmunol.0801941
Antigen-Specific Th9 Cells Exhibit Uniqueness in Their Kinetics of Cytokine Production and Short Retention at the Inflammatory Site, The Journal of Immunology, vol.185, issue.11, pp.6795-6801, 2010. ,
DOI : 10.4049/jimmunol.1001676
Th1, Th17, and Th9 Effector Cells Induce Experimental Autoimmune Encephalomyelitis with Different Pathological Phenotypes, The Journal of Immunology, vol.183, issue.11, pp.7169-7177, 2009. ,
DOI : 10.4049/jimmunol.0901906
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921715
IL- 9 production of naive CD4+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by IFN-gamma, J Immunol, vol.153, issue.9, pp.3989-3996, 1994. ,
Identification of a New Pathway for Th1 Cell Development Induced by Cooperative Stimulation with IL-4 and TGF-??, The Journal of Immunology, vol.188, issue.10, pp.4846-4857, 2012. ,
DOI : 10.4049/jimmunol.1103799
Human TH9 cells are skin-tropic and have autocrine and paracrine proinflammatory capacity T-helper type 9 cells play a central role in the pathogenesis of respiratory epithelial adenomatoid hamartoma, Sci Transl Med Medicine, vol.6, issue.21926, pp.219-227, 2014. ,
T Cells in Malignant Pleural Effusion, American Journal of Respiratory and Critical Care Medicine, vol.186, issue.11, pp.1168-1179, 2012. ,
DOI : 10.1164/rccm.201207-1307OC
Recruitment and Phenotypic Characteristics of Interleukin 9-Producing CD4+ T Cells in Malignant Pleural Effusion, Lung, vol.186, issue.Suppl 2, pp.385-389, 2013. ,
DOI : 10.1007/s00408-013-9474-4
double-positive T??cells, European Journal of Immunology, vol.6, issue.7, pp.1770-1782, 2016. ,
DOI : 10.1002/eji.201546061
URL : https://hal.archives-ouvertes.fr/inserm-01319366
mutations, International Journal of Cancer, vol.24, issue.12, pp.2912-2917, 2009. ,
DOI : 10.1002/ijc.24622
URL : https://hal.archives-ouvertes.fr/hal-01259225
Modulation of GITR for cancer immunotherapy, Current Opinion in Immunology, vol.24, issue.2, pp.217-224, 2012. ,
DOI : 10.1016/j.coi.2011.12.011
Adoptive cell transfer as personalized immunotherapy for human cancer, Science, vol.348, issue.6230, pp.62-68, 2015. ,
DOI : 10.1126/science.aaa4967
Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1, New England Journal of Medicine, vol.358, issue.25, pp.2698-2703, 2008. ,
DOI : 10.1056/NEJMoa0800251
Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?, Annals of Oncology, vol.26, issue.9, pp.1813-1823, 2015. ,
DOI : 10.1093/annonc/mdv209